JP2024502598A5 - - Google Patents
Info
- Publication number
- JP2024502598A5 JP2024502598A5 JP2023541536A JP2023541536A JP2024502598A5 JP 2024502598 A5 JP2024502598 A5 JP 2024502598A5 JP 2023541536 A JP2023541536 A JP 2023541536A JP 2023541536 A JP2023541536 A JP 2023541536A JP 2024502598 A5 JP2024502598 A5 JP 2024502598A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- ketamine
- aspirin
- amount
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135126P | 2021-01-08 | 2021-01-08 | |
| US63/135,126 | 2021-01-08 | ||
| US202163176654P | 2021-04-19 | 2021-04-19 | |
| US63/176,654 | 2021-04-19 | ||
| US202163235413P | 2021-08-20 | 2021-08-20 | |
| US63/235,413 | 2021-08-20 | ||
| PCT/US2022/011630 WO2022150597A1 (en) | 2021-01-08 | 2022-01-07 | Oral administration of ketamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502598A JP2024502598A (ja) | 2024-01-22 |
| JP2024502598A5 true JP2024502598A5 (cg-RX-API-DMAC7.html) | 2025-01-16 |
Family
ID=82323518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541536A Pending JP2024502598A (ja) | 2021-01-08 | 2022-01-07 | ケタミンの経口投与 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11382873B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4274557A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024502598A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150597A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3505157T3 (da) | 2017-12-29 | 2022-02-28 | Celon Pharma Sa | Tørpulver-ketaminsammensætning til pulmonal indgivelse ved behandlingsresistent depression |
| US20240009145A1 (en) * | 2022-07-07 | 2024-01-11 | Vitalis Analgesics LLC | Compositions of aspirin and ketamine |
| WO2025160483A1 (en) * | 2024-01-24 | 2025-07-31 | Awakn Ls Europe Holdings Limited | Oral transmucosal esketamine therapy for alcohol use disorder and substance use disorders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
| US20030035839A1 (en) * | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
| US20040224020A1 (en) * | 2002-12-18 | 2004-11-11 | Schoenhard Grant L. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
| WO2009005803A1 (en) * | 2007-07-01 | 2009-01-08 | Joseph Peter Habboushe | Combination tablet with chewable outer layer |
| CN107669649A (zh) * | 2012-10-11 | 2018-02-09 | Ix生物制药有限公司 | 固体剂型 |
| KR20220044380A (ko) * | 2013-04-12 | 2022-04-07 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 외상후 스트레스 장애의 치료 방법 |
| US20150072005A1 (en) * | 2013-09-10 | 2015-03-12 | Vitalis Llc | Aspirin formulation for increased efficacy |
| WO2018102488A1 (en) * | 2016-11-30 | 2018-06-07 | Wolfson Philip E | Ketamine for the treatment of menstrually related symptoms |
| US11471415B2 (en) * | 2017-10-10 | 2022-10-18 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation and methods of treatment |
| CN114805139B (zh) * | 2018-01-10 | 2023-10-20 | 凯瑞康宁生物工程(武汉)有限公司 | 氯胺酮的前药、其组合物和用途 |
| US20210308040A1 (en) * | 2018-10-26 | 2021-10-07 | Guangzhou Dazhou Biomedicine Ltd. | Ketamine oral transmucosal delivery system |
| AU2019447630A1 (en) * | 2019-05-31 | 2021-12-23 | Celon Pharma S.A. | Electronically supervised administration of a pharmaceutical composition |
| US20210308075A1 (en) * | 2020-04-07 | 2021-10-07 | Joseph Habboushe | Prevention and treatment of virial infections |
-
2021
- 2021-08-25 US US17/412,110 patent/US11382873B1/en active Active
-
2022
- 2022-01-07 JP JP2023541536A patent/JP2024502598A/ja active Pending
- 2022-01-07 WO PCT/US2022/011630 patent/WO2022150597A1/en not_active Ceased
- 2022-01-07 EP EP22737179.6A patent/EP4274557A4/en active Pending
- 2022-06-10 US US17/837,501 patent/US12691082B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI594754B (zh) | 口服皮質類固醇組合物 | |
| CA2690956C (en) | Combination tablet with chewable outer layer | |
| ES2236617T3 (es) | Comprimido orodispersable que presenta una gran homogeneidad y su procedimiento de preparacion. | |
| US8404275B2 (en) | Combination tablet with chewable outer layer | |
| WO2002060446A1 (fr) | Preparation medicamenteuse contenant du 5-methyle-1-phenyle-2-(1h)-pyridone en tant que principe actif | |
| US20060141031A1 (en) | Orally disintegrating pharmaceutical compositions with sensory cue agents | |
| BRPI0709719A2 (pt) | formas de dosagem sàlida revestidas de pelÍcula | |
| US5702723A (en) | Multi-stage delivery system for ingestible medications or nutrients | |
| KR20040058189A (ko) | 관능상 허용가능한 경구내 붕해 조성물 | |
| KR20030045035A (ko) | 시클로옥시게나제-2 억제제의 경구 고속-용해 제제 | |
| US20250144121A1 (en) | Compositions and methods for treating multiple sclerosis | |
| CN111065384A (zh) | 扑热息痛的口腔崩解膜组合物 | |
| RU2311176C2 (ru) | Амброксол для лечения болей в полости рта и глотки | |
| US20220008331A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
| KR20140108652A (ko) | 정제 및 건식-코팅된 작용제 | |
| US20060141027A1 (en) | Sublingual administration of non-steroidal anti-inflammatory pharmacological substances | |
| JP2021105057A (ja) | 固形製剤 | |
| Nagpal et al. | Patent innovations in fast dissolving/disintegrating dosage forms | |
| CN1537006A (zh) | 含有米尔塔扎平和对乙酰氨基酚或一种非甾类消炎药的用于治疗头痛的联合用药物 | |
| WO2024058240A1 (ja) | 感冒症状軽減剤 | |
| WO2012146314A1 (en) | Thin gelatin capsules for rapid drug release in the mouth | |
| JP6855387B2 (ja) | 圧縮成型製剤 | |
| US20220202722A1 (en) | Orodispersible tablet | |
| MXPA04003404A (es) | Composiciones de valdecoxib de disgregacion intraoral preparadas mediante un procedimiento de desecacion por pulverizacion. | |
| JP2005512990A (ja) | 流動層造粒法により製造される口腔内崩壊型バルデコキシブ組成物 |